Fulgent Genetics Liabilities 2024

Fulgent Genetics Aktienanalyse

What does Fulgent Genetics do?

Fulgent Genetics Inc. is a US company founded in 2011 by Jianxing (Justin) Liu and Ming Hsieh. The company has undergone remarkable development and is now active in the field of genomics and genetics. Fulgent Genetics' business model is based on the development and distribution of solutions for the diagnosis of genetic diseases. The company offers a variety of products and services that enable doctors, clinics, and laboratories to make effective diagnoses based on genetics. One of Fulgent Genetics' main divisions is the Clinical Diagnostics department, which offers a wide range of diagnostic products that allow for both molecular diagnoses and the creation of clinical profiles for patients. This enables doctors and clinics to quickly and accurately detect and treat specific diseases. Another important division of Fulgent Genetics is the Research department, which focuses on the discovery and development of new technologies and testing procedures. These technologies and procedures are of great interest to the scientific community and are used in research or clinical studies. Fulgent Genetics also offers a Pharmacogenomics department, which is a growing segment in the personalized medicine market. The goal here is to tailor medications to the patient's genetic makeup. Fulgent Genetics' technology allows for the analysis of a patient's current genetic makeup and recommends medications based on that. Another important area of Fulgent Genetics is the direct-to-consumer sales of tests. This is particularly significant in the field of ancestry and genealogy research. Fulgent Genetics offers a variety of tests in this area and has already achieved great success. Overall, Fulgent Genetics offers a wide range of products and services mainly focused on the diagnosis of genetic diseases. However, the company also goes beyond that and provides solutions for a wide range of customers and applications. Fulgent Genetics is based in the US and has experienced rapid growth since its founding. The company's success is also reflected in the many awards it has received. It has been recognized multiple times and has established a reputation as one of the leading biotechnology companies in the world. Fulgent Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Fulgent Genetics's Liabilities

Fulgent Genetics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Fulgent Genetics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Fulgent Genetics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Fulgent Genetics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Fulgent Genetics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Fulgent Genetics stock

What is the level of liabilities of Fulgent Genetics this year?

Fulgent Genetics has a debt balance of 99.23 M USD this year.

What were the liabilities of Fulgent Genetics compared to the previous year?

The liabilities of Fulgent Genetics have increased by -16.9% dropped compared to the previous year.

What are the consequences of high debt for investors of Fulgent Genetics?

High liabilities can pose a risk for investors of Fulgent Genetics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Fulgent Genetics?

Low liabilities mean that Fulgent Genetics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Fulgent Genetics affect the company?

An increase in liabilities of Fulgent Genetics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Fulgent Genetics affect the company?

A decrease in the liabilities of Fulgent Genetics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Fulgent Genetics?

Some factors that can influence the liabilities of Fulgent Genetics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Fulgent Genetics so important for investors?

The liabilities of Fulgent Genetics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Fulgent Genetics take to modify the liabilities?

To change its liabilities, Fulgent Genetics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Fulgent Genetics pay?

Over the past 12 months, Fulgent Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fulgent Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fulgent Genetics?

The current dividend yield of Fulgent Genetics is .

When does Fulgent Genetics pay dividends?

Fulgent Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fulgent Genetics?

Fulgent Genetics paid dividends every year for the past 0 years.

What is the dividend of Fulgent Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fulgent Genetics located?

Fulgent Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fulgent Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fulgent Genetics from 11/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Fulgent Genetics pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of Fulgent Genetics in the year 2023?

In the year 2023, Fulgent Genetics distributed 0 USD as dividends.

In which currency does Fulgent Genetics pay out the dividend?

The dividends of Fulgent Genetics are distributed in USD.